Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial

The University of Texas MD Anderson Cancer Center

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

1,337
total citations
FWCI
54.66
Percentile
100%
References
40
Citations per year

Authors

9

Topics & keywords

Keywords
  • Medicine
  • Randomization
  • Prostate cancer
  • Randomized controlled trial
  • Radiation therapy
  • Urology
  • Hazard ratio
  • Clinical endpoint
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.